Capitalizing On Cannabis: Some Sizzle In The Sector

Oct. 27, 2013 7:16 AM ET, , , , , 87 Comments

Editors' Note: This article includes micro-cap stocks. Please be aware of the risks associated with these stocks.

When I last reviewed the entire cannabis sector a month ago, I pointed to a big change: Not all of the stocks were moving in the same direction. My thesis was and remains the same: Investors are beginning to differentiate on both transparency as well as leverage to the big themes of recreational legalization and a more enthusiastic embracing of the medical benefits of marijuana. Again, the DOJ "hands-off" policy that gave the green light to Colorado and Washington to proceed with their implementations as well as Sanjay Gupta's reversal of his previously negative view on the medical aspects, both August events, paved the way for investors to sharpen their focus on these themes.

As I suggested then (note: here is a link to all of my previous articles on the sector), two of the better stocks to take advantage of these themes are GW Pharma (GWPH) for medical and GrowLife (OTC:PHOT) for recreational (but also medical). As you can see, these two stocks enjoyed a strong month:

Again, the requirement to make this list is to have a market cap, including assumed conversion of any convertible securities, of at least $10mm. Two companies on the list last month that fell off are Endexx (OTCPK:EDXC) and GreenGro Technologies (OTC:GRNH), while two names joined, including Fusion Pharm (OTC:FSPM) and Puget Technologies (OTC:PUGE). FSPM has only 5.7 million common shares, but I missed a preferred stock that converts at 100-1. This is owned primarily by the CEO, Scott Dittman, and partially by his brother. While the company sounds interesting (and is partnered in part with PHOT), the capital structure isn't very shareholder-friendly. My initial take on PUGE, which recently established Cannabis Biotech, is negative.

GWPH

This article was written by

72.29K Followers

Alan Brochstein, CFA, is one of the first investment professionals to focus exclusively on the cannabis industry. Alan got his start as a financial professional in the securities industry in 1986, managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent consulting to registered investment advisors. He is also the managing partner of New Cannabis Ventures, a leading provider of relevant financial information in the cannabis industry since 2015.

Alan has run the investing group 420 Investor, for investors interested in the publicly-traded cannabis stocks that he moved to Seeking Alpha in 2023, since 2013. As the leader of the investing group 420 Investor, Alan closely covers 20 stocks and shares investment news as it comes out, previews of their earnings reports and analysis of them afterwards. Other features of the group include: a model portfolio, 10 videos per week with chart analysis, 3 summary pieces weekly, a monthly newsletter, and chat for questions Learn More.

Recommended For You

Related Stocks

SymbolLast Price% Chg
GWPH--
GW Pharmaceuticals plc
BTZI--
BOTS, Inc.
NGBL--
Notis Global, Inc.
MJNA--
Medical Marijuana, Inc.
PHOT--
GrowLife, Inc.

Related Analysis